Agenus Inc. vs. Moderna, Inc. Common Stock
Agenus Inc. (AGEN) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| AGEN | MRNA | |
|---|---|---|
| Market Cap | $334.50 million | $56.02 billion |
| Revenue (TTM) | $132.69 million | $2.23 billion |
| Net Income (TTM) | $91.94 million | $-3,151,000,000 |
MRNA leads on 2 of 3 size & scale factors.
Valuation
| AGEN | MRNA | |
|---|---|---|
| P/E Ratio | 2.88 | — |
| Price / Book | -1.62 | 8.29 |
| Price / Sales | 2.52 | 25.15 |
AGEN leads on 2 of 2 valuation factors.
Profitability
| AGEN | MRNA | |
|---|---|---|
| Net Margin | 69.29% | -141.43% |
| Return on Equity | -44.66% | -46.61% |
AGEN leads on 2 of 2 profitability factors.
Risk & Sentiment
| AGEN | MRNA | |
|---|---|---|
| Short Interest | 22.67% | 0.01% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: AGEN overview, AGEN financials, MRNA overview, MRNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.